ReciBioPharm, a division of Recipharm, is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize advanced therapy medicinal products (ATMPs). ReciBioPharm’s specialized CDMO capabilities include pre-clinical to clinical and commercial development and manufacture for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid based mRNA and plasmid DNA production.
Led by a management team and technical experts with a proven track record in both process development and contract manufacturing, ReciBioPharm offers the knowledge and resources necessary to help customers develop and manufacture promising new therapies to meet the needs of patients across the world.
Company Details
- Employees
- 175
- Address
- Watertown, Ma 02472, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- arrantabio.com
- Keywords
- CDMO.
- HQ
- Watertown, MA
Recibiopharm Questions
Recibiopharm's website is arrantabio.com
Recibiopharm's LinkedIn profile is https://www.linkedin.com/company/recibiopharm
Recibiopharm has
175 employees.
View email and phone details for 175
employees at Recibiopharm.
Recibiopharm's industry is
Pharmaceutical Manufacturing
Recibiopharm's top competitors are
Corden Pharma - A Full-Service Cdmo,
Delpharm,
Genezen,
Sanofi,
Gsk,
Marbio,
Recipharm,
Areterna, A Synthgene Company,
Genibet Biopharmaceuticals,
Vibalogics.
Recibiopharm's categories are Pharmaceutical Manufacturing
